ARCHIVES

Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

(2)Banner (300 x 100) | Mobile | NCCN5

November 5, 2024

(2)Banner (970 x 90) | Desktop | NCCN5

November 5, 2024

Article Spotlight Article

Bureaucrats, Administrators, and Politicians

November 1, 2024

Article Spotlight Article

Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician

October 25, 2024

Article Spotlight Article

A Vote for Cancer: Tobacco Advertising and Presidential Elections

October 25, 2024

Immovable Objects and Unstoppable Forces

October 21, 2024